ABEV
Ambev S.A.
NYSE · Consumer Defensive · Beverages - Alcoholic · BR
$3.02
−0.66%Year over year
Reported trailing growth
- Revenue
- -3.8%
- EBITDA
- +1.0%
- EBIT
- +6.0%
- EPS
- +10.6%
- Free cash flow
- +10.9%
- Operating cash flow
- +6.7%
Forward estimates
Based on analyst estimates
- Revenue
- +5.8%
- EBITDA
- -7.8%
- EPS
- +1.0%
Three-year CAGR
- Revenue
- +3.4%
- EBITDA
- +7.9%
- EBIT
- +8.1%
- Net income
- +2.4%
- EPS
- +2.5%
- Free cash flow
- +12.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026